Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | proprotein convertase 2 | 0.0199 | 0.1765 | 0.1871 |
Leishmania major | hypothetical protein, conserved | 0.0351 | 0.46 | 0.5 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0199 | 0.1765 | 0.3204 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0317 | 0.3956 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0316 | 0.3944 | 0.4181 |
Brugia malayi | proprotein convertase 2 | 0.0492 | 0.7242 | 0.7242 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0199 | 0.1765 | 0.3204 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0199 | 0.1765 | 0.3204 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0199 | 0.1765 | 0.3204 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0199 | 0.1765 | 0.3204 |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.0351 | 0.46 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0122 | 0.0319 | 0.0338 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.0351 | 0.46 | 0.5 |
Echinococcus multilocularis | glycoprotein Antigen 5 | 0.0221 | 0.2164 | 0.2988 |
Echinococcus granulosus | proprotein convertase subtilisin:kexin type 5 | 0.0317 | 0.3956 | 0.4194 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.0351 | 0.46 | 0.6352 |
Echinococcus multilocularis | Mastin | 0.0221 | 0.2164 | 0.2988 |
Loa Loa (eye worm) | TK/EGFR protein kinase | 0.0122 | 0.0319 | 0.0338 |
Schistosoma mansoni | subfamily S8B non-peptidase homologue (S08 family) | 0.0199 | 0.1765 | 0.1871 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0122 | 0.0319 | 0.0338 |
Brugia malayi | Protein kinase domain containing protein | 0.0351 | 0.46 | 0.46 |
Brugia malayi | celfurPC protein | 0.0465 | 0.6732 | 0.6732 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0351 | 0.46 | 0.5 |
Brugia malayi | Kringle domain containing protein | 0.0351 | 0.46 | 0.46 |
Schistosoma mansoni | hypothetical protein | 0.0144 | 0.0732 | 0.0776 |
Loa Loa (eye worm) | hypothetical protein | 0.0351 | 0.46 | 0.4876 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.0351 | 0.46 | 0.4876 |
Loa Loa (eye worm) | endoprotease bli-4 | 0.0609 | 0.9433 | 1 |
Brugia malayi | Furin-like cysteine rich region family protein | 0.0122 | 0.0319 | 0.0319 |
Echinococcus granulosus | glycoprotein Antigen 5 | 0.0221 | 0.2164 | 0.2294 |
Toxoplasma gondii | kringle domain-containing protein | 0.0351 | 0.46 | 1 |
Echinococcus granulosus | Furin 1 | 0.0199 | 0.1765 | 0.1871 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0317 | 0.3956 | 1 |
Echinococcus granulosus | enteropeptidase | 0.0221 | 0.2164 | 0.2294 |
Schistosoma mansoni | furin-1 (S08 family) | 0.0324 | 0.4105 | 0.4351 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0221 | 0.2164 | 0.2294 |
Trichomonas vaginalis | neuroendocrine convertase 2 precursor, putative | 0.0168 | 0.1168 | 0.1353 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0199 | 0.1765 | 0.3204 |
Echinococcus multilocularis | proprotein convertase subtilisin:kexin type 5 | 0.0317 | 0.3956 | 0.5462 |
Echinococcus granulosus | neuroendocrine convertase 2 | 0.0492 | 0.7242 | 0.7677 |
Schistosoma mansoni | hypothetical protein | 0.0351 | 0.46 | 0.4876 |
Echinococcus granulosus | furin | 0.0609 | 0.9433 | 1 |
Echinococcus multilocularis | neuroendocrine convertase 2 | 0.0492 | 0.7242 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0171 | 0.1225 | 0.1299 |
Giardia lamblia | Furin precursor putative serine protease | 0.0168 | 0.1168 | 1 |
Echinococcus granulosus | tissue type plasminogen activator | 0.0351 | 0.46 | 0.4876 |
Loa Loa (eye worm) | hypothetical protein | 0.0609 | 0.9433 | 1 |
Brugia malayi | endoprotease bli-4 precursor | 0.0609 | 0.9433 | 0.9433 |
Echinococcus multilocularis | Furin 1 | 0.0199 | 0.1765 | 0.2437 |
Schistosoma mansoni | subfamily S8B unassigned peptidase (S08 family) | 0.0609 | 0.9433 | 1 |
Echinococcus granulosus | Mastin | 0.0221 | 0.2164 | 0.2294 |
Trichomonas vaginalis | proprotein convertase subtilisin/kexin type, putative | 0.0168 | 0.1168 | 0.1353 |
Echinococcus multilocularis | 0.0465 | 0.6732 | 0.9296 | |
Echinococcus multilocularis | enteropeptidase | 0.0221 | 0.2164 | 0.2988 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0122 | 0.0319 | 0.044 |
Onchocerca volvulus | 0.0351 | 0.46 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 2.5119 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 19.9526 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.